MODERATE PLAQUE PSORIASIS
Clinical trials for MODERATE PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat psoriasis: guselkumab targets sensitive areas
Disease control CompletedThis completed phase 3 trial tested the drug guselkumab against a placebo in 338 adults with moderate plaque psoriasis covering only 2-15% of their body but including special sites like the scalp, face, or genitals. The goal was to see if guselkumab could clear or nearly clear ps…
Matched conditions: MODERATE PLAQUE PSORIASIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Psoriasis showdown: which drug clears skin faster?
Disease control CompletedThis study compares two already-approved drugs, risankizumab (injection) and deucravacitinib (pill), for adults with moderate plaque psoriasis. About 393 participants who haven't used biologics before will receive one of the treatments for up to 44 weeks. The goal is to see which…
Matched conditions: MODERATE PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC